AI-Powered Cardiac Analysis

Advanced Coronary Analysis with Cleerly

Understanding coronary artery disease requires more than identifying blockages. Cleerly is an AI-powered coronary CT analysis platform designed to provide deeper, more precise insight into plaque burden, vessel health, and ischemic risk supporting earlier, more informed cardiovascular care.

Cleerly transforms coronary CT angiography (CCTA) data into detailed, quantitative analysis that helps physicians better characterize disease and guide personalized care pathways.

Physician-Led AI Intelligence

AI insights directed by experienced physicians throughout your care.

Premium Concierge

Private suites, personalized care, and dedicated support throughout your visit.

Latest Technology

Research-Grade MRI, CT, and PET/CT imaging systems for superior diagnostic accuracy.

Prime Manhattan Location

Conveniently located in the heart of Manhattan with easy access and nearby parking.

AI-Powered Analysis

Advanced machine learning quantification

Plaque Quantification

Detailed volume & composition analysis

Non-Invasive

Standard coronary CTA scan data

Risk Assessment

Ischemic risk evaluation support

Moving Beyond Anatomy Alone

Traditional coronary imaging focuses primarily on luminal narrowing. While important, this approach may not fully capture the complexity of coronary artery disease or the factors that contribute to future risk.

Cleerly applies advanced machine learning to coronary CTA images to analyze plaque composition, burden, and vessel characteristics at a more granular level. By quantifying disease rather than simply describing it, Cleerly supports a more comprehensive understanding of coronary health.

This approach enables earlier identification of risk and supports more proactive, individualized care discussions.

What Cleerly Analyzes

Plaque Volume & Burden

Plaque Composition

Stenosis Severity (2D & 3D)

Vessel & Lumen Dimensions

Ischemic Risk Indicators

Capabilities

What Cleerly Adds to Coronary CTA

Cleerly transforms standard coronary CTA data into structured, quantitative insights designed to support clinical decision-making.

Plaque Quantification

Quantifies total and non-calcified plaque volume for comprehensive disease assessment.

Composition Analysis

Characterizes plaque composition, length, and distribution across coronary segments.

2D & 3D Stenosis

Evaluates stenosis severity using both 2D (diameter/area) and 3D (lumen/vessel volume) measurements.

Vessel Analysis

Analyzes vessel and lumen dimensions across all coronary segments for complete evaluation.

Risk Assessment

Supports assessment of ischemic risk when integrated into clinical workflows.

Objective Evaluation

Moves beyond visual estimation toward more objective, reproducible evaluation of coronary artery disease.

A More Personalized Approach to Coronary Risk

Coronary artery disease develops gradually and varies significantly from patient to patient. Cleerly supports a more personalized approach by helping identify disease patterns that may not yet cause symptoms but may influence long-term risk.

By providing detailed plaque and vessel analysis, Cleerly helps physicians:

Proactive, Not Reactive

This enables care strategies that are proactive rather than reactive—addressing disease before it becomes symptomatic.

How It Works

How the Cleerly Process Works

A streamlined process from imaging to quantitative insights.
1

Coronary CTA Acquisition

High-quality coronary CT imaging is performed using advanced scanners.

2

AI-Based Image Analysis

Imaging data is processed using Cleerly's machine learning platform.

3

Quantitative Plaque & Vessel Assessment

Plaque burden, composition, and vessel characteristics are measured and quantified.

4

Physician Review

Results are reviewed within a clinical context alongside patient history.

5

Clear Results Delivery

Findings are presented in a structured, actionable format to support care planning.

How It Works

Designed for Patients and Referring Physicians

Cleerly Coronary CT Analysis provides value for both patients seeking deeper insight and physicians guiding care decisions.

For Patients

For Referring Physicians

Our Approach

Physician-Led Cardiac Imaging Program

Cleerly analysis is offered as part of a physician-guided cardiac imaging program focused on responsible use, clinical relevance, and clear communication. This ensures advanced analytics are used to support care—not replace clinical judgment.

Advanced Imaging Quality

Objective Analysis

Clear Presentation

Provider Coordination

Pricing

Choose Your Cleerly Analysis

Comprehensive AI-powered coronary analysis options.

CCTA with Cleerly

  • 20 minutes

$1,550

Advanced coronary CT angiography with AI-powered Cleerly analysis for comprehensive heart disease assessment.

  • Coronary CTA Scan
  • Cleerly AI Analysis
  • Comprehensive Plaque Characterization
  • Stenosis Assessment
  • Digital Report

CCTA with Cleerly Ischemia Analysis

  • Ischemia Analysis

$1,850

Personalized analysis and treatment planning for heart disease with advanced ischemia detection and risk stratification.

  • Coronary CTA Scan
  • Cleerly AI Analysis
  • Ischemia Assessment
  • Comprehensive Plaque Characterization
  • Detailed Digital Report
  • Personalized Treatment Plan

Frequently Asked Questions

Is Cleerly a diagnostic tool?
Cleerly provides advanced analysis of coronary CTA data to support clinical decision-making. Diagnosis and treatment decisions remain the responsibility of the treating physician.
Is Cleerly invasive?
No. Cleerly analysis is performed using data from a standard, non-invasive coronary CTA scan.
How is Cleerly different from standard CTA interpretation?
Cleerly provides quantitative plaque and vessel measurements using AI-based analysis, rather than relying solely on visual assessment.
Who reviews the results?
Results are reviewed within a physician-guided clinical framework as part of the overall imaging interpretation.

Take the Next Step Toward Deeper Coronary Insight

Cleerly Coronary CT Analysis offers a more detailed way to understand coronary artery disease—supporting personalized prevention, monitoring, and care planning.